Register to receive a free Patient Monitoring Equipment Market Report Suite for US synopsis and brochure
Omron Healthcare, the number one doctor and pharmacist recommended blood pressure monitor brand, opened pre-orders for its new HeartGuide™, the first wearable blood pressure monitor on December 20th in the United States on OmronHealthcare.com. HeartGuide, an oscillometric blood pressure monitor in the design of a wrist watch, was recently cleared by the FDA for availability as a personal medical device.
“Omron is excited to begin pre-order access to HeartGuide. Since Omron first announced this device, we have received countless messages from consumers expressing interest. As a medical-grade blood pressure device in the form of a wrist watch, HeartGuide is a breakthrough for the category and for those who want to keep a close watch on their blood pressure anytime, anywhere. HeartGuide is a key way Omron is advancing our mission of Going for Zero heart attacks and strokes,” said Omron Healthcare, Inc. President and CEO, Ranndy Kellogg.
HeartGuide functions as a digital wrist watch and uses oscillometric measurement through an innovative design – a cuff in the watch band inflates to measure clinically accurate systolic and diastolic pressure. The oscillometric method is the FDA-recognized standard for accurate, automated, medical-grade personal blood pressure measurement. Omron filed more than 80 new patents in pioneering new components for HeartGuide. Some of the miniature blood pressure pumps, valves and chips in the device are no larger than a grain of rice.
In addition to taking blood pressure measurement, HeartGuide tracks daily activity such as steps, distance and calories burned, and quality of sleep. It also provides basic smartwatch functionality such as time, date, notifications of texts, emails and calls, and the ability to set event reminders. HeartGuide will be available for $499 (USD) pre-order only in the United States, with retail availability beginning January 8, 2019.
HeartGuide will connect with an all-new, proprietary mobile app from Omron which will help users understand how their lifestyle impacts their heart health. The companion mobile app, (also arriving in January), will be free to download with the purchase of an Omron HeartGuide, will translate what blood pressure readings mean and provide personalized insights and actionable steps to take action for better heart health.
“Because blood pressure fluctuates throughout the day, regular self-monitoring empowers consumers to take immediate action on their heart health numbers and fuels a more productive patient-physician dialogue to evolve treatments and improve outcomes,” said Kellogg. “Studies show regular self-monitoring can reduce stroke risk by up to 20 percent and cut the risk of coronary artery disease by 10 percent. We created HeartGuide and its accompanying app, HeartAdvisor, to reduce those risks and to help save lives.”
According to American Heart Association and American College of Cardiology guidelines, 103 million U.S. adults are living with high blood pressure, nearly 1 in 2, and as many as 13 million are unaware they are living with this health condition.
For Further Information
More on the patient monitoring equipment market in the US can be found in a series of reports published by iData entitled the US Market Report Suite for Patient Monitoring Equipment. This report covers the following market segments: multi-parameter vital sign monitoring, wireless ambulatory telemetry monitoring, cardiac output monitoring, electromyogram monitoring (EMG), electroencephalogram monitoring (EEG), fetal and neonatal monitoring, cerebral oximetry monitoring, intracranial pressure monitoring (ICP), blood pressure monitoring, telehealth and pulse oximetry monitoring.
The iData series on the market for patient monitoring equipment covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about patient monitoring equipment market data or procedure data, register online or email us at [email protected]arch.net for a US Market Report Suite for Patient Monitoring Equipment brochure and synopsis.